Iterum Therapeutics

NASDAQ: ITRM · Real-Time Price · USD
0.83
-0.04 (-4.60%)
At close: Aug 19, 2025, 3:59 PM
0.86
3.58%
Pre-market: Aug 20, 2025, 04:06 AM EDT

Iterum Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-6.51M -4.89M -6.58M -6.09M -5M -7.1M -12.36M -3.88M -12.24M -9.89M -5.09M -29.11M -6.74M -3.5M -4.18M 3.74M 7.8M -98.92M
Depreciation & Amortization
351K 349K 261K 8K 8K 7K 440K 436K 438K 436K 439K 448K 455K 458K 1.77M 111K 185K 35K
Stock-Based Compensation
56K 61K 89K 68K 68K 138K 139K 142K 110K 393K 457K 422K 1.98M 1.9M 1.97M 1.51M 559K 281K
Other Working Capital
-549.48K 106K -836K -70.31K -1.31M -5.73M -1.8M 4.14M 362K -2.18M 809K -253K -1.38M 1.24M -796K -618K -2.3M 3.21M
Other Non-Cash Items
1.29M 1.69M 3.4M 3.42M 1.68M 3.81M 3.24M 1.3M 1.26M 2.19M -2.42M 23.51M -687K -3.31M 1.46M 2.64M 977K 3.07M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -1.57M -13.2M 960K n/a n/a n/a n/a n/a -3.28M -9.63M -15.65M 90.16M
Change in Working Capital
-187.86K -266K -1.42M -73K -3.44M -7.76M -2.34M 5.93M 1.84M -2.72M 2.35M 190K -1.28M 1.05M -193K -2.29M -2.21M 4.25M
Operating Cash Flow
-5.05M -3.06M -4.26M -2.67M -6.68M -13.08M -12.46M -9.27M -7.63M -9.59M -4.26M -4.54M -6.26M -3.4M -2.46M -3.91M -8.34M -1.13M
Capital Expenditures
-73.32 -2K -7.99 n/a -1.99K n/a 155.93 3K -16.11K n/a -45K -7K -10K n/a -13K -48K n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -15.76K -357 16.11K n/a -4.42K -15.85K 15.85K n/a 9.95M n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a -5.85M -6.49M -4.72M -9.14M -22.97M -3.89M -9.68M -1.17M -23.55M -11.31M -6.95M -5.02M -21.14M -33.92M
Sales Maturities Of Investments
n/a n/a 1.1M 5.7M 10M 13.7M 18.05M 9.5M 27.33M 9M 14.1M 17.03M 7.7M 20.9M 2.5M 9.84M n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a 0.01 7.21M -0.93 357.00 -16K 5.11K 4.42K 15.85K -15.85K 9.59M -9.95M 10M -21.14M -33.92M
Investing Cash Flow
-77.17 -2K 1.1M 5.7M 4.15M 7.21M 13.33M 360K 4.35M 5.11M 4.38M 15.85M -15.86M 9.59M -4.47M 4.93M -21.14M -33.92M
Debt Repayment
-568.93K -14.74M n/a n/a n/a n/a n/a n/a n/a n/a n/a 72.3K 57.77K -2.25M -1.49M -1.55M -1.63M -1.63M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -8.39M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -136.14K -80.2K n/a n/a
Financial Cash Flow
4.99M -8.39M 13.88M 5.43M 137.49K 7.22M 580.56K 10K 200K 235K 433K 72.3K 57.77K -2.25M -1.63M -1.63M -592K 86.98M
Net Cash Flow
374K -11.47M 10.72M 8.43M -2.41M 1.32M 1.25M -8.92M -3.1M -4.26M 573K 11.28M -22.15M 3.92M -8.54M -621K -30.07M 51.92M
Free Cash Flow
-5.05M -3.06M -4.26M -2.67M -6.76M -13.08M -12.46M -9.26M -7.65M -9.59M -4.31M -4.55M -6.27M -3.4M -2.47M -3.96M -8.34M -1.13M